Related Experiment Video
Updated: May 23, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
[Mitral valve repair for active infectious endocarditis]
Hirotaka Sato1, Yuichiro Kaminishi, Ippei Takazawa
1Department of Cardiovascular Surgery, Jichi Medical University, Shimotsuke, Japan.
Abstract:
Between December 2005 and November 2011, 11 patients with mitral valve regurgitation (MVR) resulting from native valve endocarditis underwent mitral valve plasty (MVP). These patients were aged 44.4 ± 11.3 years. The mean follow-up period of the patients was 3.1 ± 0.63 years. Five patients were men. Emergency or urgent surgery was required in 5 patients. Three patients were categorized as New York Heart Association( NYHA) functional class IV. Infection of the mitral valve, occurred in the anterior leaflet in 3 patients, the posterior leaflet in 5 patients, and the anterior-posterior leaflet in 3 patients. Nine patients had a resection suture technique. One patient had chordae replacement with expanded polytetrafluoroethylene (ePTFE), and 1 patient had replacement using the pericardium. All patients received ring annuloplasty with a partial flexible ring. After surgery, all patients were categorized as NYHA functional class I. There were no valve associated complications, no hospital deaths, no late deaths, and no reoperations. We conclude that MVP is an effective treatment for active infective endocarditis( AIE) with mitral regurgitation.
Insights
Mitral valve plasty (MVP) effectively treats mitral valve regurgitation caused by active infective endocarditis. This procedure resulted in excellent outcomes with no complications or deaths in a study of 11 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Innovation
Context:
- Native valve endocarditis frequently causes mitral valve regurgitation.
- Surgical intervention is often necessary for severe cases.
- Mitral valve plasty (MVP) is a potential treatment option.
Purpose:
- To evaluate the efficacy and safety of mitral valve plasty (MVP) in patients with mitral valve regurgitation (MVR) secondary to active infective endocarditis (AIE).
Summary:
- Eleven patients with MVR due to AIE underwent MVP between 2005 and 2011.
- Procedures included resection suture technique, chordae replacement, and ring annuloplasty.
- All patients improved to New York Heart Association functional class I post-surgery.
- No valve-related complications, mortality, or reoperations were observed during a mean follow-up of 3.1 years.
Impact:
- Mitral valve plasty demonstrates high effectiveness and safety for treating mitral valve regurgitation in the context of active infective endocarditis.
- The findings support MVP as a viable surgical strategy, potentially reducing the need for valve replacement.
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Mitral Regurgitation III: Medical Management

